Liposomes as immune adjuvants: T cell dependence

Area of Science:

• Immunology
• Vaccine Adjuvants
• Liposome Technology

Background:

• Liposomes are widely used as drug delivery vehicles and vaccine adjuvants.
• The immune response to soluble antigens can be modulated by formulation.
• T cell dependence is a critical factor in the efficacy of many vaccine strategies.

Purpose of the Study:

• To investigate the T cell dependence of liposome-encapsulated soluble antigens as immune adjuvants.
• To elucidate the role of T cells, specifically helper and suppressor populations, in liposome-mediated immune responses.
• To understand the involvement of macrophages in the adjuvant action of liposomes.

Main Methods:

• Quantitative enzyme-linked immunosorbent assay (ELISA) to measure serum antibody levels.
• Immunization studies in normal, adult thymectomized, and congenitally athymic (nu+/nu+) mice.
• Reconstitution experiments with thymocytes.
• Analysis of immunoglobulin class and subclass responses.
• Assessment of antigen presentation by macrophages.

Main Results:

• Liposome-encapsulated bovine serum albumin (Lip-BSA) induced high antibody levels in normal mice, significantly reduced in thymectomized and athymic mice.
• Reconstitution of athymic mice with thymocytes partially restored antibody production.
• Immunization with Lip-BSA elicited an IgG1-dominant response.
• Surface-exposed antigen modification reduced antibody levels.
• Liposomes stimulated both IgM and IgG antibody-producing cells in the spleen.

Conclusions:

• Liposome encapsulation of soluble T-dependent antigens stimulates helper T cells, not suppressor T cells.
• Macrophage uptake is involved in the adjuvant mechanism of liposomes.
• Liposomes act as effective adjuvants for T-dependent antigens, enhancing specific antibody production.